Virpax Pharma plunges as Nasdaq delisting looms

Virpax Pharmaceuticals

03/04/2025 16:52

** Shares of biotech firm Virpax Pharmaceuticals VRPX.O fall 55.2% to 54 cents

** VRPX's stock to be delisted from Nasdaq tomorrow for failing to meet minimum stockholders' equity requirement - SEC filing

** Co does not plan to appeal the delisting decision

** Three board members and CFO, Usama Chaudhry, have resigned from their positions, effective immediately

** Including session's move, stock down 94% YTD

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))